Skip to main content
Rahul Kumar on Muck Rack

Rahul Kumar

New Delhi, Santa Monica
As seen in: British Journal of Cancer, Nature, NDTV, ZDNet, Flipboard, Mint, Royal Society of Chemistry, BioRxiv, Cell Reports, Financial Express and
I am Modi Supporter....

Get in touch with Rahul

Contact Rahul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells | British Journal of Cancer

|
By Rahul Kumar, James Campbell, Inger Brandsma, Helen Pemberton, Fredrik Wallberg, Kinga Nagy, Beata G. Vertessy, Artur A. Serebrenik, Reuben S. Harris, Stephen Pettitt, Alan Ashworth Verified, Christopher Lord Verified, Jenni Nikkilä, Ildikó Scheer, Valentina Monni
| Nature Verified
Correction to: British Journal of Cancer https://doi.org/10.1038/bjc.2017.133, published online 23 May 2017 Following publication of the article, an error was noted in Figure 1F: The data in Fig. 1F for “293-A3B-p53 cells” were mistakenly introduced; the correct data are now displayed in Fig. 1F. About this article Nikkilä, J., Kumar, R., Campbell, J. et al.
Open in Who Shared Issue with article?

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial - Nature Medicine

|
By Grace Wong, Man-Fung Yuen, Bingliang Lin, Mark Douglas Verified, Peng Hu, Young-Suk Lim, Chia-Yen Dai, Teerha Piratvisuth, Chun-Jen Liu, Jeong Heo, Rahul Kumar, Ke Cao, Qing Zhu, Jidong Jia, Martin Weltman, Witsarut Manasirisuk
| Nature Verified
Abstract Functional cure is a goal for the treatment of chronic hepatitis B virus (HBV) infection; however, it is infrequently achieved with currently approved treatments. Here we provide a randomized evaluation of the small interfering RNA elebsiran, in combination with pegylated interferon alfa (PEG-IFNα), compared with PEG-IFNα monotherapy.
Open in Who Shared Issue with article?

Neurodevelopmental disorder mutations in the exchange factor DENN/MADD disrupt activation of Rab GTPases

|
By Rahul Kumar, Vincent Francis, Emily Banks, Luis Luna
| The Journal of Biological Chemistry Verified
Keywords Rab GTPases neurodevelopmental disorder DENN/MADD membrane trafficking cell biology guanine nucleotide exchange factor imaging protein–protein interaction genetic disease Abbreviations DENN (differentially expressed in normal and neoplastic cells domain) EGF (epidermal growth factor) GEF (guanine nucleotide exchange factor) HEK-293 (human embryonic kidney 293 cell line) MADD (mitogen-activated protein kinase–activating death domain) MAP (mitogen-activated protein) PCC (Pearson's...
Open in Who Shared Issue with article?
See all 603 licensed articles (604 Total)